These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18046092)

  • 1. The cholesterol paradox in heart failure.
    Velavan P; Huan Loh P; Clark A; Cleland JG
    Congest Heart Fail; 2007; 13(6):336-41. PubMed ID: 18046092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.
    Laufs U; Custodis F; Böhm M
    Drugs; 2006; 66(2):145-54. PubMed ID: 16451090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
    Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
    Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
    Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ
    Circulation; 2015 Dec; 132(22):e358. PubMed ID: 26621661
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
    Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
    Lin GM; Hung Y; Li YH
    Circulation; 2015 Dec; 132(22):e357. PubMed ID: 26621660
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of statins in chronic heart failure.
    Sadek MM; Haddad T; Haddad H
    Curr Opin Cardiol; 2009 Mar; 24(2):167-71. PubMed ID: 19225296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
    Mantovani A; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    Metabolism; 2018 Jun; 83():205-215. PubMed ID: 29477817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Debate: Should statin be used in patients with heart failure?
    Pietro Maggioni A
    Curr Control Trials Cardiovasc Med; 2001; 2(6):266-267. PubMed ID: 11806811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
    Røysland R; Masson S; Omland T; Milani V; Bjerre M; Flyvbjerg A; Di Tano G; Misuraca G; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Am Heart J; 2010 Aug; 160(2):286-93. PubMed ID: 20691834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
    Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
    Moccetti T; Malacrida R; Pasotti E; Sessa F; Genoni M; Barlera S; Turazza F; Maggioni AP
    Arch Intern Med; 1997 Apr; 157(8):865-9. PubMed ID: 9129546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and heart failure.
    Marchioli R; Silletta MG; Levantesi G; Pioggiarella R
    Curr Atheroscler Rep; 2009 Nov; 11(6):440-7. PubMed ID: 19852885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein in the setting of congestive heart failure: is lower really better?
    Horwich T
    Curr Atheroscler Rep; 2009 Sep; 11(5):343-9. PubMed ID: 19664377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Fonseca C; Chioncel O; Laroche C; Crespo-Leiro MG; Coats AJS; Mebazaa A; Piepoli MF; Tavazzi L; Maggioni AP;
    JACC Heart Fail; 2018 Jun; 6(6):452-462. PubMed ID: 29852929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
    Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
    Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial.
    Harris WS; Masson S; Barlera S; Milani V; Pileggi S; Franzosi MG; Marchioli R; Tognoni G; Tavazzi L; Latini R;
    Nutr Res; 2016 Sep; 36(9):989-994. PubMed ID: 27632919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Marchioli R; Schweiger C; Tavazzi L; Valagussa F
    Lipids; 2001; 36 Suppl():S119-26. PubMed ID: 11837985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.
    La Rovere MT; Staszewsky L; Barlera S; Maestri R; Mezzani A; Midi P; Marchioli R; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Heart Rhythm; 2013 Feb; 10(2):226-32. PubMed ID: 23107655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.